在急性心肌梗塞后预防心力衰竭
Jacob A Udell1, M Cecilia Bahit2, Patricia Campbell3
1Women's College Hospital, University of Toronto, Toronto, ON, Canada; Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.
Lancet (London, England)
|September 1, 2025
概括
在急性心肌梗塞 (AMI) 后预防心力衰竭方面取得了显著进展. 标准疗法降低风险,但残留风险需要个性化治疗策略以获得更好的结果.
科学领域:
- 心脏病学
- 心血管医学
- 心脏衰竭的研究
背景情况:
- 急性心肌梗塞 (AMI) 仍然是心力衰竭的主要原因.
- 全球AMI管理的护理标准,包括及时的再输血,有所改善,降低了心力衰竭的发生率.
- 既有疗法,如雷宁- 血管素- 阿尔多斯特系统抑制剂,β- 阻断剂和矿物质皮质类受体对抗剂对于心脏衰竭后的预防至关重要.
研究的目的:
- 审查心脏衰竭后的流行病学趋势和病理机制.
- 评估用于识别高风险个体的现代风险分层工具.
- 提出一个量身定制的治疗途径,并讨论未来减轻残留心力衰竭风险的策略.
主要方法:
- 四十年来流行病学数据的审查.
- 对心力衰竭病理机制的分析.
- 评估当前的风险分层工具和治疗策略.
主要成果:
- 由于改善AMI治疗和再输血,观察到心力衰竭风险的逐步降低.
- 特定药物类别在降低心脏病发作后心力衰竭风险方面的有效性.
- 尽管进行了最佳的再血管化和医疗治疗,但仍然存在残留心力衰竭风险.
结论:
- 虽然取得了显著的进展,但心脏病发作后心力衰竭的残留风险仍然存在.
- 基于个体风险分层的个性化治疗途径至关重要.
- 需要制定未来的策略,以进一步逐步降低急性心肌梗塞后心力衰竭的发生率.
更多相关视频
相关概念视频
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Heart Failure I: Introduction
52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139


